Clinical Trial Update: The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating how brown adipose tissue responds to chronic treatment with beta3-adrenergic receptor agonists in individuals with Polycy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Beta3-adrenergic receptor agonists

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Polycystic Ovary Syndrome | Phase 1 | Status: RECRUITING